12 April 2023 - final results
The AIM-listed supplier of medical instruments and associated products used in minimally invasive surgery has announced its results for 2022 and, as expected, these have shown considerable growth over the previous year. Revenues increased by 24.3% to £11.34m whilst the pre-tax loss fell to just £55k from a loss of £585k in 2021. Thanks to a tax credit, adjusted earnings per share were 0.03p compared with a loss in 2021. Net cash at the year end was £0.99m (2021: £1.76m) with the decline mainly due to increased capital . . .
This content is restricted to members only. We offer three packages from 1 month to a whole year of daily tips, market news and commentary, plus our monthly newsletters.
Registration is quick and simple HERE.
Already a member, log in HERE.
